SCHEMBL4028496

SCHEMBL4028496

Clc1ccc(-c2[nH]c(C3CCN(Cc4ccc(OCc5ccccc5)cc4)CC3)nc2-c2ccncc2)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
AKT1 P31749 10/20 0.45
AKT2 P31751 8/20 0.45
AKT3 Q9Y243 1/20 0.45
HTR2B P41595 1/20 0.44
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
MAPK13 O15264 1/20 0.42
RAF1 P04049 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42
MAPK14 Q16539 1/20 0.42
BRAF P15056 1/20 0.41
OPRL1 P41146 1/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027146 0.91 AKT1 (0.49) AKT1AKT2AKT3HTR2BMAPK13
SCHEMBL4026457 0.84 DRD4 (0.51) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL4025941 0.82 DRD2 (0.47) AKT1AKT2AKT3MAPK13RAF1
SCHEMBL4025068 0.81 GRIN2B (0.47) NPC1RAB9AMAPK13RAF1MAPK12
SCHEMBL4033810 0.80 MAPK11 (0.41) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL13810833 0.79 BRAF (0.47) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL1387891 0.79 MAPK14 (0.64) AKT1AKT2AKT3HTR2BMAPK13
SCHEMBL4026933 0.79 MAPK14 (0.64) AKT1AKT2AKT3HTR2BMAPK13
SCHEMBL8605234 0.78 NPC1 (0.47) NPC1RAB9AMAPTHTTOPRL1
SCHEMBL8605227 0.77 NPC1 (0.46) NPC1RAB9AAKT1AKT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP claimed
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP disclosed